100 related articles for article (PubMed ID: 29670383)
1. The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis.
Shelbaya A; Solem CT; Walker C; Wan Y; Johnson C; Cappelleri JC
Clinicoecon Outcomes Res; 2018; 10():213-222. PubMed ID: 29670383
[TBL] [Abstract][Full Text] [Related]
2. Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis.
Johnson C; Stephens J; Walker C; Cappelleri JC; Shelbaya A
Clinicoecon Outcomes Res; 2020; 12():57-67. PubMed ID: 32021340
[TBL] [Abstract][Full Text] [Related]
3. The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data.
Waters HC; Stellhorn R; Touya M; Fitzgerald H; Bhattacharjee S; Citrome L
J Med Econ; 2023; 26(1):316-325. PubMed ID: 36780296
[TBL] [Abstract][Full Text] [Related]
4. Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data.
Munday J; Greene M; Chang E; Hartry A; Yan T; Broder MS
Curr Med Res Opin; 2019 Jul; 35(7):1231-1239. PubMed ID: 30649965
[No Abstract] [Full Text] [Related]
5. Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs.
Yu AP; Ben-Hamadi R; Wu EQ; Kaltenboeck A; Bergman R; Xie J; Blum S; Erder MH
J Med Econ; 2011; 14(4):508-15. PubMed ID: 21692605
[TBL] [Abstract][Full Text] [Related]
6. Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.
Ungaro RC; Naegeli AN; Choong CK; Shan M; Zheng XS; Hunter Gibble T; Oneacre K; Colombel JF
Dig Dis Sci; 2024 Jan; 69(1):45-55. PubMed ID: 36920668
[TBL] [Abstract][Full Text] [Related]
7. The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records.
Corvino FA; Oliveri D; Phillips AL
Curr Med Res Opin; 2017 Jun; 33(6):1127-1132. PubMed ID: 28318337
[TBL] [Abstract][Full Text] [Related]
8. Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Lin D; Thompson-Leduc P; Ghelerter I; Nguyen H; Lafeuille MH; Benson C; Mavros P; Lefebvre P
CNS Drugs; 2021 May; 35(5):469-481. PubMed ID: 33909272
[TBL] [Abstract][Full Text] [Related]
9. Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.
Solomon DH; Husni ME; Wolski KE; Wisniewski LM; Borer JS; Graham DY; Libby P; Lincoff AM; Lüscher TF; Menon V; Yeomans ND; Wang Q; Bao W; Berger MF; Nissen SE;
Arthritis Rheumatol; 2018 Apr; 70(4):537-546. PubMed ID: 29266879
[TBL] [Abstract][Full Text] [Related]
10. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
11. Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.
Shah N; Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K; Maricich Y
Adv Ther; 2022 Sep; 39(9):4146-4156. PubMed ID: 35819569
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine.
Molife C; Haynes VS; Nyhuis A; Faries DE; Gelwicks S; Kelsey DK; Alatorre CI
Curr Med Res Opin; 2018 Apr; 34(4):619-632. PubMed ID: 29298540
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs.
Ward MA; Fang G; Richards KL; Walko CM; Earnshaw SR; Happe LE; Blalock SJ
Curr Med Res Opin; 2015 Feb; 31(2):289-97. PubMed ID: 25420131
[TBL] [Abstract][Full Text] [Related]
14. Health care costs in US patients with and without a diagnosis of osteoarthritis.
Le TK; Montejano LB; Cao Z; Zhao Y; Ang D
J Pain Res; 2012; 5():23-30. PubMed ID: 22328832
[TBL] [Abstract][Full Text] [Related]
15. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
16. Utilization of duloxetine and celecoxib in osteoarthritis patients.
Peng X; Wu N; Chen SY; Yu X; Andrews JS; Novick D
Curr Med Res Opin; 2013 Sep; 29(9):1161-9. PubMed ID: 23777314
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
Lokhandwala T; Coutinho AD; Bell CF
Clin Ther; 2021 Aug; 43(8):1320-1335. PubMed ID: 34243966
[TBL] [Abstract][Full Text] [Related]
18. Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses.
Mehta D; Davis M; Epstein AJ; Wensel B; Grinnell T; Williams GR
Neurol Ther; 2020 Dec; 9(2):585-598. PubMed ID: 32949379
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids.
Shih V; Banks E; Bonine NG; Harrington A; Stafkey-Mailey D; Yue B; Ye JM; Fuldeore RM; Gillard P
Curr Med Res Opin; 2019 Nov; 35(11):1925-1935. PubMed ID: 31290716
[No Abstract] [Full Text] [Related]
20. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
